Merger of four GSK businesses into a single £1.5bn UK & Ireland business, including the acquisition of Maxinutrition

“…you’ve done tremendous work for us… We very much enjoyed working with you – you were a key part of the team that helped put this business together and we have much to be grateful for…”

— Peter Harding, General Manager, GSK UK & Ireland



GSK 1


As a member of newly formed GB&I Leadership team, a Global PMI Partners Associate Partner led the programme to create a world-class, superior, and unified Consumer Healthcare business (including brands such as Sensodyne, Aquafresh, Ribena, Lucozade, MaxiNutrition, Panadol and Beechams.)

3 core objectives were delivered:

  • Created an integrated, single business, by merging four separate businesses, which collectively represented £1.5bn gross sales;
  • Accelerated growth levels from low single digit to high single digit by year 2 of implementation and to outgrow key competitors by delivering sustainable growth; and
  • Implemented key changes from strategic growth lever workstreams, including commercial execution, supply chain, category and brand management, talent and culture, and scientific innovation

This highly successful engagement led onto a further requirement to support the transformation of the global R&D function



Sector/s
Healthcare

Services Delivered
M&A Integration

Countries Involved
Ireland
United Kingdom


We use cookies to give you the best experience with our website. By continuing to browse this site, you are agreeing to our use of cookies. For more on how we use information collected, please see our Privacy Policy.